Compounds for the treatment of neuropsychiatric disorders
AssigneeCuremark, LLC
InventorsJoan M. Fallon, Matthew Heil, James Szigethy, James Fallon
Life of this patent
Estimating the term…
Loading patent…
AssigneeCuremark, LLC
InventorsJoan M. Fallon, Matthew Heil, James Szigethy, James Fallon
Estimating the term…
Described herein are compositions which include digestive enzymes and which are formulated to reduce one or more symptoms of a neuropsychiatric disorder. Also described herein is a method for treating an individual with a neuropsychiatric disorder using digestive enzymes and their derivatives to alleviate the symptoms of neuropsychiatric disorders. The method comprises administering to the individual an effective amount of digestive enzymes that are either naturally or recombinantly derived, or their derivatives, in an amount effective to reduce one or more symptoms of the neuropsychiatric disorder.
A method for preventing or treating a patient exhibiting one or more symptoms of a neuropsychiatric disorder comprising administering a therapeutically effective amount of a composition comprising digestive enzymes to the individual, wherein one or more symptoms of said neuropsychiatric disorder are treated.
A method for preventing or treating one or more symptoms of schizophrenia or psychosis in a patient administering a therapeutically effective amount of a composition comprising digestive enzymes to the individual, wherein said one or more symptoms of schizophrenia or psychosis are treated.
A composition comprising digestive enzymes for use in the prevention or treatment of one or more symptoms of a neuropsychiatric disorder.
A composition comprising digestive enzymes for use in the prevention or treatment of one or more symptoms of schizophrenia or psychosis.
Dependencies are inferred from the claim text.